Invivyd, Inc. — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-11-01

Reporting Person: Andersen Jill (Chief Legal Officer, Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-01	Stock Option (Right to Buy)	$30.65	A	514863	Acquired	2031-10-31	Common Stock (514863)	Direct

Footnotes

F1: One quarter (1/4) of the option shall vest on November 1, 2022, and thereafter, the remainder of the option shall vest in 36 equal monthly installments on the 1st day of each month, subject to the Reporting Person's continuous service on each vesting date.